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ABSTRACT The biological basis of voluntary exercise is complex and simultaneously controlled by peripheral (ability) and central
(motivation) mechanisms. The accompanying natural reward, potential addiction, and the motivation associated with exercise are
hypothesized to be regulated by multiple brain regions, neurotransmitters, peptides, and hormones. We generated a large (n = 815)
advanced intercross line of mice (G4) derived from a line selectively bred for increased wheel running (high runner) and the C57BL/6J
inbred strain. We previously mapped multiple quantitative trait loci (QTL) that contribute to the biological control of voluntary exercise
levels, body weight, and composition, as well as changes in body weight and composition in response to short-term exercise. Currently,
using a subset of the G4 population (n = 244), we examined the transcriptional landscape relevant to neurobiological aspects of
voluntary exercise by means of global mRNA expression profiles from brain tissue. We identified genome-wide expression quantitative
trait loci (eQTL) regulating variation in mRNA abundance and determined the mode of gene action and the cis- and/or trans-acting
nature of each eQTL. Subsets of cis-acting eQTL, colocalizing with QTL for exercise or body composition traits, were used to identify
candidate genes based on both positional and functional evidence, which were further filtered by correlational and exclusion mapping
analyses. Specifically, we discuss six plausible candidate genes (Insig2, Socs2, DBY, Arrdc4, Prcp, IL15) and their potential role in the
regulation of voluntary activity, body composition, and their interactions. These results develop a potential initial model of the
underlying functional genomic architecture of predisposition to voluntary exercise and its effects on body weight and composition
within a neurophysiological framework.
VOLUNTARY exercise levels are considerably variable inmice (e.g., Lightfoot et al. 2004) and humans (e.g., Cen-
ters for Disease Control and Prevention (CDC) 2003); may
be an important predictor of human health-related quality of
life (Booth et al. 2000; Friedenreich and Orenstein 2002);
and are influenced by multiple environmental variables, ge-
netic factors, and their interactions (review by Garland et al.
2011b). Furthermore, multiple lines of evidence suggest
that the biological basis of voluntary exercise behavior is
composed of both ability and motivation (Waters et al.
2008; Meek et al. 2009; reviewed in Knab and Lightfoot
2010; Garland et al. 2011b). These two components are
almost certainly not mutually exclusive in their contribution
to voluntary exercise, their relative influence may vary
among individuals, and each undoubtedly has a genetic ba-
sis (Dishman 2008; Bray et al. 2009).
From a neurobiological perspective, exercise in humans
and rodents is hypothesized to be self-rewarding (e.g., Brené
et al. 2007), potentially addictive (MacLaren and Best
2010), and a highly motivated behavior (Sherwin 1998).
For example, Sherwin and Nicol (1996) demonstrated that
mice are motivated to engage in wheel running, even when
the cost of gaining access to a wheel is increased by requir-
ing shallow water traverses. Not only are mice apparently
willing to incur a cost to gain access to a running wheel, but
also operant conditioning studies have demonstrated that
both rats and mice are motivated to lever press for the op-
portunity to run (Belke 2006; Belke and Garland 2007). In
addition, selective breeding for both elevated endurance
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capacity in rats and elevated wheel running in mice has
resulted in alterations to neurobiological pathways that ap-
pear to delay the onset of exercise-induced fatigue (rats:
Foley et al. 2006) and increase motivation for wheel-running
behavior (mice: Rhodes et al. 2005). Although a detailed
understanding of the neurobiology of exercise is still years
away, potential mechanistic foundations include multiple
brain regions encompassing interactions between neuro-
transmitters, peptides, and hormones (see figure 1 in Kotz
et al. 2008; figure 5 in Garland et al. 2011b). More specifi-
cally, pharmacological experiments on mice selectively bred
for elevated wheel running have implicated alterations in
dopamine function (Rhodes et al. 2005; Knab and Lightfoot
2010; Mathes et al. 2010) and endocannabinoid signaling
(Keeney et al. 2008) as underlying the neurobiology of high
voluntary exercise.
In addition to voluntary exercise, dopamine and endo-
cannabinoid signaling, among other central nervous system
processes, have also been linked to aspects of eating
behavior and obesity (Cagniard et al. 2006; Davis et al.
2008; Garland et al. 2011b). The interactions of these re-
dundant neural systems are currently poorly understood
(Lenard and Berthoud 2008), but it has been demonstrated
in mice (Kumar et al. 2010) and humans (Cai et al. 2006)
that food intake and physical activity, both components of
energy balance, may be governed by a similar underlying
genetic architecture. For example, Mathes et al. (2010) ob-
served significant differential gene expression, with associ-
ated changes in the dopamine pathway (D1 and D2
receptors), G-proteins, and adenylate cyclase in mice selec-
tively bred for either high running or obesity relative to
a nonselected outbred strain of mice.
Previously, we generated an advanced intercross line
(AIL; G4) of mice that is broadly useful for investigation of
the phenotypic relationships and genetic architecture of vol-
untary exercise behavior and related body composition
traits. The AIL was created through reciprocal crosses be-
tween a line selectively bred for high voluntary wheel run-
ning and the inbred strain C57BL/6J (Kelly et al. 2010a).
The use of an AIL (as opposed to an F2 population) resulted
in a threefold expansion of the genetic map (Kelly et al.
2010b) and led to increased QTL mapping resolution with
reduced confidence intervals (C.I.’s) (Farber et al. 2011).
The high-runner (HR) line utilized in creation of the AIL is
a result of a replicated artificial selection experiment for
increased voluntary wheel-running behavior on days 5 and
6 of a 6-day wheel exposure (Swallow et al. 1998). The HR
lines have diverged significantly from the control lines with
an 2.5- to 3-fold increase in total revolutions/day with
correlated changes in a number of morphological, physio-
logical, and behavioral traits (reviewed in Swallow et al.
2009; Garland et al. 2011a).
Using this AIL, we have previously reported multiple QTL
for voluntary exercise traits including daily wheel running
(distance, duration, average speed, and maximum speed),
running values averaged across days 5 and 6 of the 6-day
test, and the running trajectory (slope and intercept) across
the wheel-access period (Kelly et al. 2010b). We have also
localized QTL controlling relationships between voluntary
exercise, food consumption, and changes in body weight
and composition (Kelly et al. 2011). In this report, as a com-
plementary approach to further our understanding of the
genetic architecture of exercise and its relationship with
changes in body weight and composition, we examined
global gene expression profiles in brain tissue. By combining
QTL mapping with large-scale gene expression analysis, our
primary goal was to further dissect these complex traits and
make the selection of candidate genes underlying predispo-
sition loci more efficient (e.g., Pomp 2005). By initially using
brain tissue, we attempted to capture the transcriptional
landscape relevant to motivational aspects of voluntary ex-
ercise. Expression quantitative trait loci (eQTL) were iden-
tified, their additive and dominance gene action calculated,
and the cis- and/or trans-acting nature determined. Subsets
of cis-acting eQTL that mapped under loci for exercise or
body composition traits were used to produce a list of po-
tential candidate genes on the basis of their genomic posi-
tion and/or known function. Combined with correlational
and exclusion mapping analyses, these results begin to de-
velop a more detailed description of the underlying genetic
architecture of predisposition to voluntary exercise and its




A G4 population (n = 815) was generated from a reciprocal
cross between mice selectively bred for high voluntary
wheel running (HR line) and the inbred strain C57BL/6J
(B6). Details regarding the creation and phenotyping of
the G4 population have been described elsewhere (Kelly
et al. 2010a). Only methodological details relevant to the
current suite of phenotypes and the corresponding statistical
analyses will be described here. Details regarding the final
set of SNPs utilized for the QTL analyses (n = 530), with an
average genome-wide spacing of 4.7 Mb, have been pro-
vided elsewhere (Kelly et al. 2010b), and complete geno-
types are provided in the Supporting Information, File S1.
G4 mice at 8 weeks of age were assessed for body
weight and composition (percentage fat tissue and percent-
age lean tissue) (EchoMRI-100, Echo Medical Systems,
Houston, TX) and then were individually housed with access
to running wheels (circumference = 1.1 m) (Lafayette
Instruments, Lafayette, IN; model 80850) for 6 sequential
days. Voluntary running was recorded electronically at 1-
min intervals for 23–24 hr daily. The following daily traits
were calculated: distance (total revolutions), time spent
running (cumulative 1-min intervals in which at least 1 rev-
olution was recorded), average speed (total revolutions/
time spent running), and maximum speed (highest number
of revolutions in any 1-min interval within a 24-hr period).
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In addition, we calculated mean values of the above traits on
days 5 and 6 of the 6-day test, and the slope and intercept
for regressions of distance, time, average speed, and maxi-
mum speed across the 6 days of wheel exposure. After body
weight and composition measures were taken on day 6,
mice were decapitated and brains were immediately har-
vested, placed on a chilled aluminum block, separated into
left and right hemispheres, flash-frozen in liquid nitrogen,
and stored at 280. Percentage change in body mass in re-
sponse to 6 days of voluntary wheel running was calculated as
[(pre-wheel mass – post-wheel mass)/pre-wheel mass] · 100.
Percentage change (after wheel access) in percentage body
fat (and lean) was calculated as [(% post-wheel access –
% pre-wheel access)/% pre-wheel access] · 100. All proce-
dures were approved by and were conducted in accordance
with the guidelines set forth by the Institutional Animal Care
and Use Committee at the University of North Carolina at
Chapel Hill.
RNA isolation and microarray analysis
Total RNA was isolated and purified from a homogenate of
the right hemisphere of the brain from a subset of the G4
population using TRIzol (Invitrogen, Carlsbad, CA). The sub-
population (n = 244) was utilized due to financial limitations
in running microarrays and represented the population-wide
variation in running distance. Among the subpopulation, each
of two parent-of-origin types [whether a G4 individual was
descended from a progenitor (F0) cross of HR♀ · B6♂ or
B6♀ · HR♂] and sexes were equally represented, as these
two factors have known effects on wheel-running behavior
and body composition-related traits (see Kelly et al. 2010a).
Within each of the four subpopulation categories, the 62
individuals were nonrandomly chosen to represent the
entire distribution of running distance (i.e., low, moderate,
and high runners) observed across each subpopulation
and across the full population. Four individuals were re-
moved from the final analyses due to a lack of genotype
information.
Following isolation and purification, RNA quality and
quantity was determined by spectrophotometry (Nano-
Drop ND-1000, NanoDrop Technologies, Wilmington, DE)
and bio-analysis (Genomics and Bioinformatics Core Facil-
ity, Lineberger Comprehensive Cancer Center, University of
North Carolina School of Medicine, Chapel Hill, NC).
Expression profiles were generated for 45,281 transcripts
using the MouseWG-6 v2.0 Beadchip (Illumina, San Diego)
and processed utilizing Microarray Services (Expression
Analysis; Durham, NC). Following Gordon et al. (2010),
transcript expression profiles were normalized using
Loess-Quantile normalization methods with R v 2.8.1 sta-
tistical software (R Development Core Team, 2008; http://
www.r-project.org, lumi package) (see File S2). Tran-
scripts with a detection score $0.95 were considered to
be expressed above background and utilized for correla-
tion and eQTL (Burns et al. 2010; Gordon et al. 2010;
O’Leary and Osborne 2011).
Correlation analysis
Phenotypic correlations were calculated using SAS (version
9.1, SAS Institute, Cary, NC) between all genes significantly
expressed above background levels and exercise and body
composition phenotypes previously measured in the G4 pop-
ulation. In an attempt to determine if sex or parent-of-origin
type were potentially underlying significant correlations
with transcript levels, partial correlations were calculated
adjusting for both factors (Kelly et al. 2010b, 2011). For
all correlation analyses, adjustments for multiple compari-
sons were performed in SAS using the false-discovery-rate
procedure controlling the overall type I error rate at 5%
(Curran-Everett 2000).
eQTL analysis
eQTL were identified using the multiple imputation method
(Sen and Churchill 2001) within R/qtl (Broman et al. 2003)
for the R environment. Statistical models included effects of
sex and parent of origin. Permutation (n = 1000) tests of
100 randomly selected transcripts yielded an average signif-
icance threshold of a log of the odds (LOD) . 3.8 (an ap-
proach similar to van Nas et al. 2010). This average
threshold was calculated using R/qtl, which assumes an F2
population structure and therefore independence among
individuals. We acknowledge that our approach is only one
of potentially many and that the threshold estimates may be
imperfect in the context of available techniques. As new
approaches that are more computationally efficient (e.g.,
Zhang et al. 2012) and applicable to the current data set
become available, thresholds computed here may be revisited.
Due to our more complex breeding history (G4 as op-
posed to F2), some adjustment of the LOD threshold is war-
ranted (Valdar et al. 2009). The subpopulation utilized here
(n = 248) was composed of 54 unique families with an
average of four individuals representing each family (me-
dian = 4; minimum = 1; maximum = 11). For comparison,
57 unique families (average = 13 individuals per family;
median = 13; minimum = 4; maximum = 28) were repre-
sented in the overall QTL mapping population (n = 815).
Hence, we did not statistically account for family structure
as in previous studies (see Kelly et al. 2010b, 2011). Rather,
given the reduced population size, short number of inter-
crosses, and the relatively well-balanced mating design in
our G4, we chose the expedient approach of setting a higher
LOD threshold; eQTL with LOD ratio scores.4.3 (P-value,
0.00005) were deemed significant (previously chosen by
Schadt et al. 2003). In addition, we chose to highlight only
candidate genes with high relative LOD scores or extensive
existing functional support (as in the case of arrestin domain
containing 4, or Arrdc4). We computed the distance of the
mapped location of significant eQTL to the midpoint of
the physical location of the gene that each represented. If
the distance was #10 Mb, eQTL were classified as cis-acting
or local eQTL. If the distance was .10 Mb (including on
another chromosome), eQTL were classified as trans-acting
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or distant (following Doss et al. 2005). In addition, the per-
centage variation explained and the additive and dominance
effects of each significant cis- and trans-acting eQTL were
estimated in R/qtl (see Kelly et al. 2011).
Exclusion mapping analysis
For a subset of candidate genes uncovered by eQTL analysis,
we examined gene regions to determine if the haplotypes of
the parental strains (HR and B6) were identical by descent
(IBD) utilizing SNPs from the Mouse Diversity array (Yang
et al. 2009). We genotyped a subset of representative indi-
viduals from the F0 parental strains (n =12, HR; n =1, B6)
using the complete Mouse Diversity array containing
623,124 SNPs. We utilized these SNPs to determine (1)
whether the interval is homozygous or heterozygous in
each sample and (2) whether samples are IBD in each ho-
mozygous interval. As previously described in Farber et al.
(2011), we determined the frequency of heterozygous calls
in windows of 200 consecutive SNPs in each one of the 12
HR individuals independently. We then identified intervals
that are IBD among all 12 HR founders and B6 using the
same 200-SNP window and threshold (.97% genotype
identity) approach used to identify the segregating regions
(following Farber et al. 2011).
Results
Correlation analysis
Following Loess-Quantile normalization, 17,571 (of 45,281)
transcripts were identified with a detection score (calculated
across all 244 mice) $0.95. Non-normalized and normal-
ized transcript files are provided in File S3, File S4, and File
S5. Pearson partial correlations were generated between
these transcripts and a total of 36 exercise-related pheno-
types and 17 traits related to body weight, body composi-
tion, and change in body weight and composition as a result
of 6 days of exercise. Correlations were adjusted for factors
with known phenotypic effects (sex and parent of origin).
After adjustment for multiple testing, 348 (0.04% of total
possible) partial correlations were found to be statistically
significant (P # 0.05), indicating putative functional rele-
vance (Figure 1). Relationships between exercise-related
traits and transcript levels accounted for the largest propor-
tion (61.8%) of observed significant correlations (Figure 1).
Among the exercise traits, running duration represented the
largest percentage of significant relationships with transcript
levels (48.6%). Collectively, body weight and composition-
related traits accounted for 37.3% of significant correlations
(Figure 1). Changes in body weight and composition, as a re-
sult of 6 days of exercise, represented only 0.006% of signif-
icant correlations with transcript levels. Greatest-magnitude
correlations between exercise/body composition traits and
transcript levels are presented in Table S1.
Notably, adjusted partial correlations revealed that Insig2
was significantly correlated with body mass post exercise
(r=20.33, P= 0.0166; top correlation, see Table S1), with
running duration on day 1 (r = 0.30, P = 0.0362), with the
trajectory of running duration across all 6 days (r = 20.34,
P = 0.0084), and with the intercept of running duration
(r = 0.32, P = 0.0084).
eQTL analysis
In total, 2441 cis-acting and 2164 trans-acting statistically
significant eQTL were observed (Figure 2, A and B). Cis-acting
eQTL were distributed genome-wide. The average LOD
score for cis-acting eQTL was 18.7 (range = 4.3–108.2),
while for trans-acting eQTL the mean LOD score was 15.0
with a range of 4.3–92.9. Among 100 randomly selected,
statistically significant, trans-acting eQTL the average size
of the 95% C.I. (defined by one LOD drop) was 15.9 Mb
Figure 1 The number of statistically significant (P # 0.05,
adjusted for multiple comparisons) partial correlations, ad-
justed for sex and parent of origin, factors with known
phenotypic effects (see Kelly et al. 2010a) between
17,571 significantly expressed transcripts, and exercise
and body composition-related phenotypes. In total, 36
exercise-related phenotypes and 17 traits related to food
consumption, body weight and composition, and change
in body weight and composition as a result of 6 days of
voluntary exercise on wheels were observed. Therefore,
each of the phenotypes depicted above is composed of
multiple traits (n depicted following each phenotype) that
are each highly correlated with one another (see correla-
tion analyses in Kelly et al. 2010b, 2011).
646 S. A. Kelly et al.
(median = 15.3 Mb) with an average of 30.5 (median =
24.0) transcripts physically residing with the C.I.’s. Among
cis-acting eQTL, the median distance of the mapped location
to the midpoint of the physical location of the gene was 1.94
Mb, and the distance was negatively correlated with the
significance level (Figure 2C). For comparison, in early gen-
erations of a mouse recombinant inbred strain panel, the
pre-Collaborative Cross, the median liver eQTL-gene dis-
tance was 0.92 Mb (Aylor et al. 2011). In addition, in an
outbred mouse population (MF1 stock; Harlan, Indianapo-
lis), the median distance of eQTL peak markers from the
physical gene location was 0.67 Mb, and for 25% of the
genes eQTL-gene distance was ,300 kb (Ghazalpour et al.
2008). Trans-acting eQTL were identified on all chromo-
somes, with a potential master regulatory region observed
on the distal end of Chr. 1 at 170–180 Mb based; 332
trans-acting eQTL mapping to this region (Figure 2B).
Significant cis-acting eQTL individually explained, on av-
erage, 26.35% of the total phenotypic variation for mRNA
abundance of the underlying transcript, with a median per-
centage variance explained of 19.63% and a range of 0.45–
86.65%. Average additive effects for cis-acting eQTL were
almost universally statistically significant (98.4% or 2404 of
2441), with increasing expression as a result of the HR allele
comprising 42% (n = 998) and increasing expression as
a result of the B6 allele comprising 58% (n = 1406) of
the total. In addition, average dominance effects were gen-
erally small with little statistical significance. Furthermore,
we observed significant dominance effects only in the ab-
sence of significant additive effects for three cis-acting eQTL:
BC020354 (Chr. 20, gene location: 147.42 Mb; eQTL loca-
tion: 138.78 Mb); Slc22a17 (Chr. 14, gene location: 55.53
Mb; eQTL location: 63.19 Mb); and Arrdc4 (Chr. 7, gene
location: 75.89 Mb; eQTL location: 76.26 Mb). Uniquely,
Arrdc4 mapped under a previously detected QTL (82.6 Mb,
C.I. = 75–86 Mb) for running duration on day 1 (of a 6-day
exposure to running wheels), which also displayed significant
dominance effects in the absence of significant additive ef-
fects (Kelly et al. 2010b).
Significant trans-acting eQTL individually explained, on
average, 10.38% of the total phenotypic variation for mRNA
abundance of the underlying transcript with a median
percentage variance explained of 8.74% and a range of
0.01–86.90%. Average additive effects for trans-acting eQTL
were generally large and frequently statistically significant
(76.7% or 1659 of 2164), with increasing effects as a result
of the HR allele comprising 49.5% (n = 821) and increas-
ing effects as a result of the B6 alleles comprising 50.5%
Figure 2 (A) The number of local or cis-acting (black bars) and distant or
trans-acting (gray bars) eQTL across all chromosomes with a LOD $ 4.3.
(B) Physical gene location as a function of mapped position of each QTL.
The prominent diagonal band indicates cis-acting eQTL. A potential mas-
ter regulatory region is observed on the distal end of chromosome 1, as
indicated by a prominent vertical trans-band. Complete data file utilized
to generate Figure 2B is provided in File S6. (C) Cis-acting eQTL were
defined as falling within 10 Mb of the gene’s physical location, with
the most significant eQTL generally being the closest to the gene’s mid-
point.
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(n = 838) of the total. In addition, average dominance
effects were large and statistically significant for 673 eQTL.
Among these trans-acting eQTL, dominance was frequently
found in the absence of significant additive effects. Trans-
eQTL composing the potential master regulatory region lo-
cated on the distal end of Chr. 1 similarly displayed additive
effects that were frequently significant. Significant domi-
nance effects were also noted for 102 of 332 eQTL located
in the potential master regulatory region.
Using the larger G4 population of which a subset was
analyzed in the present study, we previously identified 39
significant and 18 suggestive QTL representing various ex-
ercise traits (Kelly et al. 2010b). Here, we compared the
locations of cis-acting eQTL within the C.I.’s (defined by 1
LOD drop) of QTL observed for subsets of the mean exercise
traits (distance, duration, average speed, and maximum
speed) on days 1 and 2 (Figure 3B) and on days 5 and 6
of the 6-day wheel-access period (Figure 3, A and C–F).
Comparisons between cis-acting eQTL and running dis-
tance QTL (mean on days 5 and 6) revealed 30 positional
candidate genes on Chr. 7 (Figure 3A and Table S2), all with
significant additive effects and little dominance. For running
distance on day 1, 20 potential candidate genes were iden-
tified under 2 QTL on Chr. 1, with all having significant
additive effects with little dominance. On day 2, 17 over-
lapping candidate genes were identified under one signifi-
cant QTL (Figure 3B and Table S2). For mean running
duration on days 5 and 6, we identified 40 candidate genes
on Chr. 7, with 30 overlapping with running distance (Fig-
ure 3C and Table S2). The additional 10 candidate genes
unique to running duration resulted from an expansion of
the C.I.’s for running duration loci (91–129 Mb) as com-
pared to the C.I. for the running distance QTL (99–124
Mb) and also displayed significant additive effects. In total,
we observed 50 statistically significant cis-acting eQTL that
mapped under the previously identified QTL for an average
running speed on days 5 and 6 of the 6-day wheel exposure.
Thirty candidate genes were located on Chr. 2 (Figure 3D
and Table S2) and the remaining 20 candidate genes were
observed on Chr. 14 (Figure 3E and Table S2). Of these,
similar to those described above, eQTL generally had large
and statistically significant additive effects with little domi-
nance. For maximum running speed (on days 5 and 6), 33
candidate genes were identified on Chr. 2 with 30 overlap-
ping with those identified for running speed (Figure 3D and
Table S2). In addition, 53 candidate genes, with significant
additive effects, were identified on Chr. 11 for maximum
running speed (Figure 3F and Table S2).
In addition to comparisons between cis-acting eQTL and
exercise QTL, we examined colocalizing cis-acting eQTL
and loci previously identified for change in body weight
and body composition in response to exercise. Comparisons
between cis-acting eQTL and loci observed for percentage
change in body mass, as a result of 6 days of exercise, re-
vealed 18 candidate genes on Chr. 11 (Figure 4A and Table
S2). For percentage change in percentage fat mass (as de-
scribed in Kelly et al. 2011) we identified 36 candidate
genes on Chr. 1 and 40 on Chr. 5 (Figure 4, B and C; Table
S2). In addition, we observed 27 candidate genes on Chr.
5 for percentage change in percentage lean mass, all of
which overlapped with those identified for percentage
change in percentage fat mass (Figure 4D and Table S2).
In general, eQTL had large significant additive effects with
little dominance.
Of the cis-acting eQTL identified above, Insig2 was among
the most statistically significant (LOD = 100.0; physical lo-
cation: 124 Mb) and mapped near the peaks of the follow-
ing previously identified trait QTL: body mass pre-exercise
(peak: 116 Mb), body mass post exercise (106 Mb), run-
ning distance on day 1 (113 Mb) and day 2 (134 Mb),
intercept of running distance (123 Mb), running duration
on day 1 (136 Mb), trajectory of running duration (123
Mb), and intercept of running duration (134 Mb). Insig2
was also mapped to 83.0 Mb on Chr. 7 (trans-acting,
LOD = 7.4). In addition, IL15 (physical location: Chr. 8 at
84.86 Mb) was mapped (83.9 Mb, LOD = 45.9) under
previously identified loci for percentage fat mass and per-
centage lean mass (post exercise; see Kelly et al. 2011). Two
additional cis-acting candidate genes of interest (discussed
below) were prolylcarboxypeptidase, angiotensinase C (Prcp:
physical location: Chr. 7 at 100.08 Mb), which mapped to
93.0 Mb (LOD = 99.5); and Arrdc4 (physical location = Chr.
7 at 75.89 Mb), which mapped to 76.3 Mb (LOD = 4.4).
Both potential candidate genes mapped under previously
identified loci for exercise related traits.
Exclusion mapping
In isolated cases, we characterized the pattern of haplotype
diversity in the founders. The haplotype analysis was used to
identify if the select candidate genes fell within a region of
IBD, making them a lower priority, or in segregating regions,
making them a higher priority. We performed a detailed
investigation of the cis-acting eQTL for Insig2, IL15, Prcp, and
Arrdc4. These loci were chosen because they were among the
most statistically significant and/or because they directly
mapped under the confidence intervals of a variety of pre-
viously identified phenotypic QTL related to exercise and/or
body composition. On the basis of the characterization of the
pattern of haplotype diversity in the founders, we concluded
that Insig2, IL15, Prcp, and Arrdc4 all fell within a segregating
region of the genome as opposed to IBD regions.
Discussion
Only two genes have been identified, on the basis of rodent
studies, as potentially strong candidates involved in the
regulation of physical activity: dopamine receptor 1 (Drd1)
and nescient helix loop helix 2 (Nhlh2) (Lightfoot 2011).
Combining QTL mapping with large-scale gene expression
analysis (Jansen and Nap 2001), or eQTL mapping, is be-
coming increasingly commonplace in a variety of organisms
(e.g., Druka et al. 2010; Liu 2011; Parts et al. 2011) and has
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Figure 3 Cis-acting eQTL colocalizing with exercise QTL. Colocalizing candidate genes that fell within the confidence intervals of the trait QTL are
depicted. The LOD score of the eQTL is shown on the left y-axis, the phenotype (exercise trait) LOD score on the right y-axis, and the position of both on
the x-axis. Each transcript is labeled, and color is used only for the purpose of demarcation. Inset lists of transcripts are in the corresponding order of their
vertical position. (A) Mean running distance (Chr. 7) on days 5 and 6 of a 6-day test. (B) Running distance (Chr. 1) on each of days 1(black line) and 2
(gray line). (C) Mean running duration (Chr. 7) on days 5 and 6 of a 6-day test. (D) Average (black line) and maximum (gray line) running speed (Chr. 2)
on days 5 and 6 of a 6-day test. (E) Average running speed (Chr. 14) on days 5 and 6 of a 6-day test. (F) Maximum running speed (Chr. 11) on days 5 and
6 of a 6-day test.
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made the selection of candidate genes underlying predispo-
sition loci more efficient. Here we used approaches similar to
those described by Lightfoot (2011) to identify candidate
genes potentially playing a role in the regulation of voluntary
exercise (wheel running), body composition, and their inter-
actions. For specific candidate genes, we discuss these analyses
in the context of existing functional studies. To our knowledge,
an approach that bridges the gap between the neurophysiol-
ogy of, and genetic predisposition to, voluntary exercise and
body composition-related traits has not been addressed.
Mode of gene action
Here, we examined the percentage of phenotypic variance
explained and the average additive and dominance effects of
all statistically significant cis- and trans-acting eQTL (n =
4605 in total). While the cis-acting eQTL, on average,
explained a much higher percentage (more than twice the
amount) of the total phenotypic variation, the range of var-
iance explained by cis- and trans-acting eQTL was very similar
(0.45–86.65% vs. 0.01–86.90%, respectively). Some trans-
acting eQTL explained a very high percentage of the total
phenotypic variation, and this can in part be explained by
how we chose to define trans-acting eQTL: as the eQTL lo-
cated .10 Mb from the gene’s physical midpoint. Therefore,
per this definition, derived from statistical effects not biolog-
ical ones (see Schadt et al. 2003), a trans-acting eQTL may be
mapped to the same chromosome and even as close as 10.5
Mb from the physical midpoint of the gene. However, this was
certainly not the rule, as the trans-acting eQTL that explained
the highest percentage of phenotypic variance (86.90%) were
not mapped to the same chromosome as the physical location
of the gene. Although average additive effects were gener-
ally large across all eQTL, they were large and most per-
vasive for cis-acting eQTL (98.4% as opposed to 76.7% for
trans-acting of the total). Conversely to what was observed
for additive effects, dominance appeared to play a lesser
Figure 4 Cis-acting eQTL, colocalizing with QTL underlying changes in body weight and composition in response to 6 days of voluntary wheel running
(Kelly et al. 2010b). Colocalizing candidate genes that fell within the confidence intervals of the trait QTL are depicted. The LOD score of the eQTL is
shown on the left y-axis, the phenotype (exercise trait) LOD score on the right y-axis, and the position of both on the x-axis. Each transcript is labeled,
and color is used only for the purpose of demarcation. Inset lists of transcripts are in the corresponding order of their vertical position. (A) Percentage
change in body mass (Chr. 11). (B) Percentage change in percentage fat mass (Chr. 1). (C) Percentage change in percentage fat mass (Chr. 5). (D)
Percentage change in percentage lean mass (Chr. 5).
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role for the cis-acting eQTL, while, for the trans-acting
eQTL, dominance effects were more frequently large and
statistically significant.
Similar differences, as noted here, in mode of gene action
have been previously observed in an F1 hybrid diversity
panel of Arabidopsis thaliana (Zhang et al. 2011). Zhang
et al. tested 21,803 expression traits (from the fifth or sixth
true leaf) with 56,819 genome-wide SNPs and observed
a tendency for locally associated SNPs to be additively
inherited, while distantly related SNPs were mostly domi-
nant. Zhang et al. (2011) also observed that additive effects
were generally larger than dominant ones and more fre-
quently fell into local regulatory regions.
Although the increasing effects resulting from each of the
founder alleles (HR and B6) were nearly identical among
the trans-acting eQTL, among the cis-acting eQTL increasing
effects as a result of the B6 allele were more pervasive. The
allelic bias among cis-acting eQTL may potentially reflect
probe bias toward the strain-specific reference genome used
to design microarray probes or directional detection of func-
tional polymorphisms (see Verdugo et al. 2010). Alterna-
tively, the differences in gene action between HR and B6
may be reflective of different historical selective forces,
a chief difference being the artificial selection of the HR
strain for increased voluntary activity.
Identification of potential candidate genes
Many genes were identified with multiple lines of evidence
implicating them as candidates for exercise QTL; here we
discuss selected examples only. While we discuss single
candidate genes here, we acknowledge that the combined
effects of multiple linked eQTL could potentially cause
phenotypic QTL. One highly significant (LOD = 100.0) cis-
acting eQTL located on Chr. 1 (123.2 Mb), Insig2 (insulin-
induced gene 2), colocalized with loci previously identified
for exercise and body composition-related traits. Insig2 has
been implicated in the functional regulation of lipid and
cholesterol metabolism, positively (Herbert et al. 2006; Lyon
et al. 2007) and negatively (Dina et al. 2007) associated
with human obesity, associated with cholesterol biosynthe-
sis, and characterized as a strong candidate susceptibility
gene for total plasma cholesterol levels.
A subnetwork of Insig2 consisted of several additional
genes (BC014805, Socs2, and Mod1) also implicated in obe-
sity phenotypes (Cervino et al. 2005). In the present study,
a trans-acting eQTL was mapped for Socs2 (physically lo-
cated on Chr. 10 at 94.8 Mb) to Chr.1 at 170 Mb, a locus
previously identified for percentage change in percentage
adiposity in response to 6 days of wheel running.
Interleukin (IL)-15a (cytokine-specific receptor) knockout
mice have been shown to exhibit a leaner phenotype with
lower fat composition, elevated home-cage activity and heat
dissipation (light and dark phases), greater food intake (light
phase only), and raised oxygen consumption (light phase
only) (He et al. 2010). In the present study, an eQTL for
IL15 was mapped to Chr. 8 (cis-acting, LOD = 45.9) and
Chr. 1 (trans-acting, LOD = 5.5), colocalizing with previously
identified QTL for body composition and wheel-running
traits, respectively. Furthermore, IL15 expression level was
significantly correlated with running duration, body mass,
and percentage fat mass.
Prcp was found to be a highly significant (LOD = 99.5) cis-
acting eQTL mapped to 93.0 Mb on Chr. 7, a region contained
within the confidence intervals of previously (see Kelly et al.
2010b) identified QTL for running distance and duration (see
Figure 3C and Kelly et al. 2010b). Wallingford et al. (2009)
observed that the inhibition of Prcp activity in vivo decreased
food intake in wild-type and obese mice, and Prcp-null mice
were leaner and shorter than wild-type controls and resistant
to high-fat diet-induced obesity (Wallingford et al. 2009).
Similar phenotypes have been observed in the HR strain of
mice utilized here (Swallow et al. 1999; Kelly et al. 2006;
Vaanholt et al. 2008).
A cis-acting eQTL for Arrdc4 was mapped under a previ-
ously detected QTL for running duration on day 1, and nota-
bly both the QTL and eQTL displayed significant dominance
effects in the absence of significant additive effects. Arrdc4
has been shown to alter glucose metabolism (Patwari et al.
2009), and in cancer cells is induced under lactic acidosis and
repressed with glucose deprivation (Chen et al. 2010). Nota-
bly, HRmice have previously demonstrated adaptive plasticity
in GLUT-4 abundance (Gomes et al. 2009), possibly indicat-
ing that the relationship between running duration and glu-
cose usage may be facilitated through Arrdc4.
A final candidate, DBY or Ddx3y [DEAD (Asp-Glu-Ala-Asp)
box polypeptide 3], is located on the Y-chromosome gene. We
did not attempt to map eQTL for DBY (due to a lack of markers
on the Y chromosome), but did identify several highly signifi-
cant correlations between DBY expression levels and exercise
and body composition traits (see Table S1). The significant
correlations were large and were present only when relation-
ships were not adjusted for sex or parent-of-origin type. Dby
mRNA is retained in mouse spermatozoa and important for
male zygotic development, possibly implicating a mechanistic
role for spermatozoa mRNA during embryonic stages (Yao et al.
2010a,b). Previously, we demonstrated significant parent-of-or-
igin effects on a variety of exercise and body composition traits,
with these effects being most pronounced for males in some
cases (Kelly et al. 2010a). Given the current results, we hypoth-
esize that DBY, via the early environment of the zygote, may in
part explain the large parent-of-origin effects.
Limitations to the current approach
Perhaps surprisingly, genes regulating dopamine signaling
were not expressed above background in the present study.
While other studies (e.g., Bronikowski et al. 2004; Mathes et al.
2010) have targeted specific brain regions (e.g., dorsal striatum
and nucleus accumbens, hippocampus), we chose to use the
entire right hemisphere of the brain, which may have caused
significant signal dilution and, in effect, led us to miss addi-
tional important candidate genes. We acknowledge that an
alternative approach would have been to target a specific brain
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region previously implicated in the regulation of exercise be-
havior (see Introduction for examples). In our opinion, there is
no one particular brain region sufficient to account for the di-
versity of behavioral and physiological traits measured in the G4
population (e.g., running distance, weight regulation, food con-
sumption). Our compromise was to bisect the hemispheres, run
our initial expression assays on one hemisphere, and reserve the
remaining hemisphere for potential follow-up studies in a more
focused/targeted fashion. This strategy, we believe, takes ad-
vantage of the fact that 186 of the top 500 genes expressed
in the brain are expressed in all cell types (Lein et al. 2006).
In addition to not utilizing a localized brain region, we
also recognize the possible limitations of the current QTL/
microarray approach of identifying candidate genes (poten-
tial limitations are discussed at length in Verdugo et al.
2010). While we acknowledge these potential pitfalls, they
did not restrict our approach to the current eQTL analysis.
Therefore, although we provide supporting evidence for the
proposed potential candidate genes above, we acknowledge
that our results are most strongly relevant to the current
methods, and caution should be taken when generally ex-
trapolating these findings. In addition to the support pro-
vided here, additional lines of evidence will be needed
(described in Lightfoot 2011) to validate the functional role
of these candidate genes, especially with regard to voluntary
exercise behavior. Regardless, the proximate goal of the in-
tegrative genomics approach adopted here is efficient gene
discovery relevant to predisposition to engage in voluntary
activity and the resultant modification of body composition.
The ultimate goal is to use these results to adopt better-
informed approaches to using physical activity as a preven-
tative and therapeutic treatment for chronic disease.
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Exercise	  /	  	  
Body	  Composition	  Trait	  
n	   Partial	  r	  
Running	  distance	  
ILMN_2961216	   Slco2a1	   Day	  1	   234	   0.3138*	  
ILMN_2729958	   Hist1h3d	   	   	   	  
ILMN_2768972	   Fam107a	   Day	  2	   234	   0.3090*	  
ILMN_2899599	   DBY	   	   	   	  
ILMN_1227564	   A930003O13	   Day	  3	   240	   0.3509*	  
ILMN_2899599	   DBY	   	   	   	  
ILMN_2763294	   Ensa	   Day	  4	   217	   -­‐0.3374*	  
ILMN_2951691	   Hist1h3h	   	   	   	  
ILMN_2768972	   Fam107a	   Day	  5	   244	   0.3223*	  
ILMN_2729958	   Hist1h3d	   	   	   	  
ILMN_1247361	   Abhd12	   Day	  6	   244	   0.3634*	  
ILMN_2729958	   Hist1h3d	   	   	   	  
ILMN_2768972	   Fam107a	   (Days	  5	  +	  6)/2	   244	   0.3554*	  
ILMN_2729958	   Hist1h3d	   	   	   	  
ILMN_1222194	   Tln2	   Slope	  (days	  1-­‐6)	   207	   -­‐0.2900	  
ILMN_1222194	   Tln2	   	   	   	  
ILMN_2990229	   Snrnp25	   Intercept	  (days	  1-­‐6)	   207	   -­‐0.2889	  
ILMN_2899599	   DBY	   	   	   	  
Running	  time	  
ILMN_1225769	   Clasp1	   Day	  1	   234	   -­‐0.3331*	  
ILMN_2899599	   DBY	   	   	   	  
ILMN_2768972	   Fam107a	   Day	  2	   234	   0.3274*	  
ILMN_2899599	   DBY	   	   	   	  
ILMN_2742840	   Gpr34	   Day	  3	   240	   -­‐0.3847*	  
ILMN_2899599	   DBY	   	   	   	  
ILMN_2951691	   Hist1h3h	   Day	  4	   217	   0.4074*	  
ILMN_2951691	   Hist1h3h	   	   	   	  
ILMN_2951691	   Hist1h3h	   Day	  5	   244	   0.3771*	  
ILMN_2951691	   Hist1h3h	   	   	   	  
ILMN_2951691	   Hist1h3h	   Day	  6	   244	   0.3330*	  
ILMN_2951691	   Hist1h3h	   	   	   	  
ILMN_2951691	   Hist1h3h	   (Days	  5	  +	  6)/2	   244	   0.4381*	  
ILMN_1234453	   Hist1h3h	   	   	   	  
ILMN_2628567	   Phlda3	   Slope	  (days	  1-­‐6)	   207	   -­‐0.3853*	  
ILMN_2628567	   Phlda3	   	   	   	  
ILMN_2628567	   Phlda3	   Intercept	  (days	  1-­‐6)	   207	   0.3558*	  
ILMN_2899599	   DBY	   	   	   	  
S.	  A.	  Kelly	  et	  al.	  4	  SI	  
Average	  running	  speed	  
ILMN_2961216	   Slco2a1	   Day	  1	   234	   0.3116*	  
ILMN_2509327	   Wipf3	   	   	   	  
ILMN_2847787	   Emr1	   Day	  2	   234	   -­‐0.3189*	  
ILMN_2768972	   Fam107a	   	   	   	  
ILMN_2619107	   Lgals1	   Day	  3	   240	   -­‐0.3125*	  
ILMN_1228867	   TCR-­‐alpha	   	   	   	  
ILMN_2619107	   Lgals1	   Day	  4	   217	   -­‐0.3062*	  
ILMN_2619107	   Lgals1	   	   	   	  
ILMN_1222543	   Ugt1a6a	   Day	  5	   244	   0.3132*	  
ILMN_1222543	   Ugt1a6a	   	   	   	  
ILMN_1222543	   Ugt1a6a	   Day	  6	   244	   0.3235*	  
ILMN_1222543	   Ugt1a6a	   	   	   	  
ILMN_1222543	   Ugt1a6a	   (Days	  5	  +	  6)/2	   244	   0.3252*	  
ILMN_1222543	   Ugt1a6a	   	   	   	  
ILMN_2685150	   Tmub2	   Slope	  (days	  1-­‐6)	   207	   -­‐0.2905	  
ILMN_2685150	   Tmub2	   	   	   	  
ILMN_2847787	   Emr1	   Intercept	  (days	  1-­‐6)	   207	   -­‐0.3069	  
ILMN_2847787	   Emr1	   	   	   	  
Maximum	  running	  speed	  
ILMN_1240553	   Htra2	   Day	  1	   234	   0.2635	  
ILMN_1257365	   Thra	   	   	   	  
ILMN_3135781	   Anxa3	   Day	  2	   234	   -­‐0.2792	  
ILMN_1250057	   D10Ertd610	   	   	   	  
ILMN_1250057	   D10Ertd610	   Day	  3	   240	   0.2726	  
ILMN_1250057	   D10Ertd610	   	   	   	  
ILMN_1250057	   D10Ertd610	   Day	  4	   217	   0.2618	  
ILMN_2765513	   Kif3a	   	   	   	  
ILMN_1252338	   Cyp2d22	   Day	  5	   244	   0.2730	  
ILMN_2675289	   Amn	   	   	   	  
ILMN_1252338	   Cyp2d22	   Day	  6	   244	   0.2589	  
ILMN_2719794	   BC003331	   	   	   	  
ILMN_1252338	   Cyp2d22	   (Days	  5	  +	  6)/2	   244	   0.2717	  
ILMN_2675289	   Amn	   	   	   	  
ILMN_2685150	   Tmub2	   Slope	  (days	  1-­‐6)	   207	   -­‐0.2607	  
ILMN_2482178	   Ociad2	   	   	   	  
ILMN_2624854	   Gstm2	   Intercept	  (days	  1-­‐6)	   207	   -­‐0.2990*	  
ILMN_1224331	   A830006F12	   	   	   	  
ILMN_2678336	   Ctf1	   Food	  intake	   243	   -­‐0.2796	  
ILMN_1244316	   Hbb-­‐b1	   	   	   	  
ILMN_1229203	   Hbb-­‐b1	   Food	  intake	  /	  g	   242	   0.3043*	  
ILMN_2899599	   DBY	   	   	   	  
S.	  A.	  Kelly	  et	  al.	   5	  SI	  
~8	  wk	  of	  age	  
ILMN_1233149	   AK038694	   Body	  mass,	  g	   243	   0.3546*	  
ILMN_2899599	   DBY	   	   	   	  
ILMN_2984110	   Plvap	   %	  Fat	   243	   0.3198*	  
ILMN_1244316	   Hbb-­‐b1	   	   	   	  
ILMN_2692723	   Lpl	   %	  Lean	   243	   -­‐0.2823	  
ILMN_2981689	   Nup133	   	   	   	  
Post	  exercise	  
ILMN_2690256	   Insig2	   Body	  mass,	  g	   243	   -­‐0.3348*	  
ILMN_2899599	   DBY	   	   	   	  
ILMN_2825109	   Zfp330	   %	  Fat	   243	   -­‐0.3422*	  
ILMN_2825109	   Zfp330	   	   	   	  
ILMN_2825109	   Zfp330	   %	  Lean	   243	   0.3431*	  
ILMN_2638354	   Prdx2	   	   	   	  
ILMN_1229203	   Hbb-­‐b1	   %	  Change	  in	  body	  mass	   243	   0.2522	  
ILMN_2937548	   Hist1h4m	   	   	   	  
ILMN_2880536	   Uck2	   %	  Change	  in	  %	  fat	  	   243	   -­‐0.3149*	  
ILMN_2745370	   Sult1a1	   	   	   	  
ILMN_2622089	   5430432N15	   %	  Change	  in	  %	  lean	   243	   0.2695	  
ILMN_2622089	   5430432N15	   	   	   	  
	  
	  *P	  <	  0.05,	  **P	  <	  0.001	  
S.	  A.	  Kelly	  et	  al.	  6	  SI	  
Table	  S2	  	  Candidate	  genes	  based	  on	  proximity	  to	  QTL	  for	  exercise	  and	  change	  in	  body	  weight/composition	  in	  
response	  to	  exercise.	  	  For	  partial	  (adjusted	  for	  sex	  and	  parent	  of	  origin)	  correlations,	  *	  indicates	  significance	  at	  P	  ≤	  
0.05	  after	  correction	  for	  multiple	  comparisons	  
ProbeID	   Gene	  Symbol	   Chr	   LOD	  
eQTL	  peak	  
(Mb)	  
eQTL	  to	  Gene	  
(Mb)	  




Running	  Distance,	  (Days	  5+6)/2	  
ILMN_121555
0	   Inppl1	   7	   11.1	   108.92	   0.05	   0.02	   0.09	  
ILMN_122094
8	   Trrp2	   7	   4.5	   108.92	   0.31	   0.02	   -­‐0.11	  
ILMN_121581
8	   4933439J20Rik	   7	   14.7	   108.92	   0.31	   0.02	   -­‐0.04	  
ILMN_123534
7	   Frag1	   7	   29.5	   108.92	   0.47	   0.02	   0.02	  
ILMN_254046
4	   LOC381904	   7	   14.9	   108.92	   1.09	   0.02	   0.03	  
ILMN_124280
2	   Rab6	   7	   16.9	   108.92	   1.14	   0.02	   -­‐0.04	  
ILMN_123613
1	   Mrpl48	   7	   11.5	   108.92	   1.22	   0.02	   -­‐0.10	  
ILMN_281715
1	   Chchd8	   7	   22.9	   108.92	   1.23	   0.02	   0.18	  
ILMN_272099
5	   Pold3	   7	   23.5	   108.92	   1.69	   0.02	   -­‐0.02	  
ILMN_276056
8	   2900057K09Rik	   7	   42.9	   108.92	   1.85	   0.02	   0.00	  
ILMN_277735
9	   Serpinh1	   7	   16.8	   108.92	   2.42	   0.02	   -­‐0.01	  
ILMN_282472
3	   Fxc1	   7	   27.7	   108.92	   3.87	   0.02	   0.03	  
ILMN_264908
3	   Clns1a	   7	   18.2	   108.92	   4.07	   0.02	   0.09	  
ILMN_291488
4	   Tmem9b	   7	   5.3	   108.92	   7.96	   0.02	   0.06	  
ILMN_287540




k	   7	   24.2	   112.05	   0.47	   3.15	   0.01	  
ILMN_295694
2	   Prkcdbp	   7	   27.5	   112.05	   0.58	   3.15	   -­‐0.06	  
ILMN_286898
7	   Smpd1	   7	   15.9	   112.05	   0.65	   3.15	   0.01	  
ILMN_296484
1	   Ppfibp2	   7	   7.8	   114.94	   0.05	   6.04	   0.08	  
ILMN_121925
3	   Olfml1	   7	   13.2	   114.94	   0.20	   6.04	   -­‐0.12	  
ILMN_121653
4	   E130307J04Rik	   7	   25.8	   114.94	   1.25	   6.04	   -­‐0.04	  
ILMN_121634
1	   3110041P15Rik	   7	   5.1	   114.94	   2.04	   6.04	   -­‐0.09	  
ILMN_270599
1	   Cln2	   7	   6.0	   114.94	   2.04	   6.04	   -­‐0.02	  
ILMN_262359
1	   Apbb1	   7	   32.0	   114.94	   2.23	   6.04	   -­‐0.03	  
S.	  A.	  Kelly	  et	  al.	   7	  SI	  
ILMN_122189
2	   C130064E22Rik	   7	   4.6	   114.94	   2.24	   6.04	   -­‐0.06	  
ILMN_274628
3	   Mrvi1	   7	   8.0	   114.94	   3.07	   6.04	   0.09	  
ILMN_121631
3	   Stim1	   7	   8.6	   114.94	   5.52	   6.04	   -­‐0.02	  
ILMN_261970
7	   Slco2b1	   7	   6.5	   114.94	   8.13	   6.04	   -­‐0.14	  
ILMN_291356
3	   Crym	   7	   15.1	   122.38	   4.95	   13.48	   -­‐0.03	  
ILMN_275872
8	   Lcmt1	   7	   68.7	   122.38	   8.14	   13.48	   0.09	  




k	   1	   16.6	   3.46	   1.31	   0.04	   -­‐0.07	  
ILMN_125274
3	   Mrpl15	   1	   11.5	   3.46	   1.32	   0.04	   0.12	  
ILMN_267506
4	   Adhfe1	   1	   6.6	   9.99	   0.45	   6.49	   -­‐0.03	  
ILMN_122576
9	   5930424F13Rik	   1	   29.4	   115.56	   4.84	   2.86	   -­‐0.26	  
ILMN_124699
9	   Ddx18	   1	   6.5	   115.56	   7.89	   2.86	   0.08	  
ILMN_123504
7	   3110009E18Rik	   1	   35.9	   122.52	   0.44	   9.82	   -­‐0.23	  
ILMN_315015
9	   Dbi	   1	   5.8	   122.52	   0.51	   9.82	   0.11	  
ILMN_269025
6	   Insig2	   1	  
100.
0	   122.52	   0.68	   9.82	   0.23	  
ILMN_263045
9	   Cxcr4	   1	   9.4	   122.52	   7.96	   9.82	   -­‐0.04	  
ILMN_124429
2	   Sox13	   1	   5.3	   134.31	   0.97	   21.61	   0.03	  
ILMN_262519
7	   Ptprv	   1	   18.2	   134.31	   2.70	   21.61	   0.01	  
ILMN_268078








k	   1	   5.4	   134.31	   5.56	   21.61	   -­‐0.13	  
ILMN_277772
2	   Jarid1b	   1	   70.2	   136.28	   0.25	   23.58	   0.19	  
ILMN_124602
4	   Rnpep	   1	   14.9	   136.28	   0.88	   23.58	   0.16	  
ILMN_288301
6	   Nav1	   1	   32.8	   136.28	   1.06	   23.58	   0.13	  
ILMN_126037
8	   Csrp1	   1	   50.5	   136.28	   1.37	   23.58	   0.13	  
ILMN_262856
7	   Phlda3	   1	   70.1	   136.28	   1.39	   23.58	   0.22	  
ILMN_263957
9	   4732493F09Rik	   1	   6.0	   136.28	   6.44	   23.58	   -­‐0.02	  
Running	  Distance,	  Day	  2	  
ILMN_122576
9	   5930424F13Rik	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   29.4	   115.56	   115.56	   18.74	   -­‐0.22	  
ILMN_124699 Ddx18	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   6.5	   115.56	   115.56	   18.74	   0.12	  
S.	  A.	  Kelly	  et	  al.	  8	  SI	  
9	  
ILMN_123504
7	   3110009E18Rik	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   35.9	   122.52	   122.52	   11.78	   -­‐0.17	  
ILMN_315015
9	   Dbi	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   5.8	   122.52	   122.52	   11.78	   0.17	  
ILMN_269025
6	   Insig2	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	  
100.
0	   122.52	   122.52	   11.78	   0.23	  
ILMN_263045
9	   Cxcr4	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   9.4	   122.52	   122.52	   11.78	   -­‐0.01	  
ILMN_124429
2	   Sox13	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   5.3	   134.31	   134.31	   0.01	   0.02	  
ILMN_262519
7	   Ptprv	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   18.2	   134.31	   134.31	   0.01	   -­‐0.13	  
ILMN_268078








k	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   1	   5.4	   134.31	   134.31	   0.01	   -­‐0.21	  
ILMN_277772
2	   Jarid1b	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   70.2	   136.28	   136.28	   1.98	   0.22	  
ILMN_124602
4	   Rnpep	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   14.9	   136.28	   136.28	   1.98	   0.12	  
ILMN_288301
6	   Nav1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   32.8	   136.28	   136.28	   1.98	   0.13	  
ILMN_126037
8	   Csrp1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   50.5	   136.28	   136.28	   1.98	   0.19	  
ILMN_262856
7	   Phlda3	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1 70.1	   136.28	   136.28	   1.98	   0.19	  
ILMN_263957
9	   4732493F09Rik	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   6.0	   136.28	   136.28	   1.98	   -­‐0.03	  
Running	  Duration,	  (Days	  5+6)/2	  
ILMN_316222
4	   0610007P06Rik	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	   5.6	   93.00	   4.07	   15.90	   0.20	  
ILMN_125517
5	   AW538196	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	   4.8	   93.00	   5.53	   15.90	   0.10	  
ILMN_263915
5	   2510048K03Rik	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	   99.5	   93.00	   7.08	   15.90	   -­‐0.09	  
ILMN_121555
0	   Inppl1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	   11.1	   108.92	   0.05	   0.02	   0.16	  
ILMN_122094
8	   Trrp2	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	   4.5	   108.92	   0.31	   0.02	   -­‐0.08	  
ILMN_121581
8	   4933439J20Rik	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	   14.7	   108.92	   0.31	   0.02	   -­‐0.15	  
ILMN_123534
7	   Frag1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	   29.5	   108.92	   0.47	   0.02	   -­‐0.09	  
ILMN_254046
4	   LOC381904	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	   14.9	   108.92	   1.09	   0.02	   0.11	  
ILMN_124280
2	   Rab6	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	   16.9	   108.92	   1.14	   0.02	   -­‐0.13	  
ILMN_123613
1	   Mrpl48	   7	   11.5	   108.92	   1.22	   0.02	   -­‐0.14	  
ILMN_281715
1	   Chchd8	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	   22.9	   108.92	   1.23	   0.02	   0.31*	  
ILMN_272099
5	   Pold3	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	   23.5	   108.92	   1.69	   0.02	   -­‐0.10	  
ILMN_276056 2900057K09Rik	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	   42.9	   108.92	   1.85	   0.02	   -­‐0.13	  
S.	  A.	  Kelly	  et	  al.	   9	  SI	  
8	  
ILMN_277735
9	   Serpinh1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	   16.8	   108.92	   2.42	   0.02	   0.04	  
ILMN_282472
3	   Fxc1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	   27.7	   108.92	   3.87	   0.02	   -­‐0.04	  
ILMN_264908
3	   Clns1a	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	   18.2	   108.92	   4.07	   0.02	   0.11	  
ILMN_291488
4	   Tmem9b	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	   5.3	   108.92	   7.96	   0.02	   0.12	  
ILMN_287540




k	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   7	   24.2	   112.05	   0.47	   3.15	   -­‐0.04	  
ILMN_295694
2	   Prkcdbp	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	   27.5	   112.05	   0.58	   3.15	   -­‐0.07	  
ILMN_286898
7	   Smpd1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7 15.9	   112.05	   0.65	   3.15	   -­‐0.03	  
ILMN_296484
1	   Ppfibp2	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	   7.8	   114.94	   0.05	   6.04	   0.05	  
ILMN_121925
3	   Olfml1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	   13.2	   114.94	   0.20	   6.04	   -­‐0.09	  
ILMN_121653
4	   E130307J04Rik	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	   25.8	   114.94	   1.25	   6.04	   -­‐0.09	  
ILMN_121634
1	   3110041P15Rik	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	   5.1	   114.94	   2.04	   6.04	   -­‐0.02	  
ILMN_270599
1	   Cln2	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	   6.0	   114.94	   2.04	   6.04	   -­‐0.06	  
ILMN_262359
1	   Apbb1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	   32.0	   114.94	   2.23	   6.04	   -­‐0.10	  
ILMN_122189
2	   C130064E22Rik	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	   4.6	   114.94	   2.24	   6.04	   -­‐0.10	  
ILMN_274628
3	   Mrvi1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	   8.0	   114.94	   3.07	   6.04	   0.20	  
ILMN_121631
3	   Stim1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	   8.6	   114.94	   5.52	   6.04	   0.00	  
ILMN_261970
7	   Slco2b1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	   6.5	   114.94	   8.13	   6.04	   -­‐0.15	  
ILMN_291356
3	   Crym	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	   15.1	   122.38	   4.95	   13.48	   -­‐0.18	  
ILMN_275872
8	   Lcmt1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	   68.7	   122.38	   8.14	   13.48	   0.21	  
ILMN_122945
8	   Prkcb	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	   7.5	   125.73	   4.04	   16.83	   -­‐0.06	  
ILMN_124367




k	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   7	   8.1	   125.73	   7.29	   16.83	   -­‐0.16	  
ILMN_273239
4	   Giyd2	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	   17.4	   125.73	   8.10	   16.83	   0.09	  
ILMN_121364
5	   AI467606	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	   9.9	   125.73	   8.50	   16.83	   0.18	  
ILMN_274204
2	   Nupr1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7 12.4	   128.31	   5.45	   19.41	   -­‐0.09	  
ILMN_262958
1	   Cox6a2	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	   7.2	   128.31	   7.04	   19.41	   0.00	  
Average	  Running	  Speed,	  (Days	  5+6)/2	  
ILMN_121290 D430039N05Ri 2	   62.1	   82.78	   0.95	   16.22	   0.12	  
S.	  A.	  Kelly	  et	  al.	  10	  SI	  
7	   k	  
ILMN_308893
4	   2700094K13Rik	   2	   4.7	   82.78	   1.73	   16.22	   0.09	  
ILMN_296655
8	   Ypel4	   2	   59.6	   82.78	   1.80	   16.22	   0.14	  
ILMN_125447
3	   LOC241525	   2	   67.6	   82.78	   1.80	   16.22	   0.09	  
ILMN_277542
1	   Serping1	   2	   8.2	   82.78	   1.83	   16.22	   0.05	  
ILMN_289529
3	   BC003993	   2	   96.6	   82.78	   5.04	   16.22	   -­‐0.07	  
ILMN_275671
6	   Nup160	   2	   52.5	   82.78	   7.80	   16.22	   0.04	  
ILMN_284858
3	   Mtch2	   2	   17.3	   82.78	   7.93	   16.22	   0.05	  
ILMN_279176
9	   Ddb2	   2	   7.9	   82.78	   8.28	   16.22	   -­‐0.03	  
ILMN_124148








k	   2	   76.7	   89.55	   1.21	   9.45	   -­‐0.09	  
ILMN_268913




k	   2	   30.8	   89.55	   2.21	   9.45	   0.05	  
ILMN_122723
5	   Timm13a	   2	   13.0	   89.55	   4.88	   9.45	   0.06	  
ILMN_122066
4	   Nckap1	   2	   8.8	   89.55	   9.21	   9.45	   0.09	  
ILMN_258901
5	   Pacsin3	   2	   14.6	   91.83	   0.73	   7.17	   -­‐0.05	  
ILMN_274719
6	   Kai1	   2	   9.0	   91.83	   1.43	   7.17	   -­‐0.12	  
ILMN_296075
0	   Traf6	   2	   6.8	   99.04	   2.50	   0.04	   0.03	  
ILMN_251176
8	   Ttc17	   2	   6.3	   99.04	   4.90	   0.04	   0.00	  
ILMN_262930
7	   4732486I23Rik	   2	   17.4	   99.04	   5.55	   0.04	   0.12	  
ILMN_122937
9	   Syt13	   2	   10.3	   99.04	   6.24	   0.04	   -­‐0.06	  
ILMN_122369
7	   Cd44	   2	   4.4	   102.76	   0.10	   3.76	   0.01	  
ILMN_273741
6	   Fjx1	   2	   43.1	   102.76	   0.47	   3.76	   -­‐0.04	  
ILMN_282611
0	   Cat	   2	   42.9	   102.76	   0.54	   3.76	   -­‐0.14	  
ILMN_313152
2	   Fbxo3	   2	   10.6	   102.76	   1.14	   3.76	   0.06	  
ILMN_266076
6	   Cd59b	   2	   19.2	   102.76	   1.16	   3.76	   0.07	  
ILMN_123442
4	   G2-­‐pending	   2	   18.4	   102.76	   1.23	   3.76	   0.15	  
ILMN_314541
5	   Cstf3	   2	   4.8	   102.76	   1.69	   3.76	   0.15	  




k	   2	   35.3	   102.76	   1.77	   3.76	   0.07	  
ILMN_264733
1	   Nfatc4	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  14	   5.8	   66.14	   9.69	   13.76	   0.13	  
ILMN_258931
2	   Entpd4	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  14	   39.1	   69.46	   0.53	   10.44	   -­‐0.13	  
ILMN_299499
5	   Lgi3	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  14	   31.6	   69.46	   1.48	   10.44	   0.20	  
ILMN_279352
2	   Tnfrsf19	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  14	   9.1	   69.46	   7.88	   10.44	   0.02	  
ILMN_268012
8	   3110050K21Rik	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  14	   6.2	   76.86	   1.14	   3.04	   -­‐0.10	  
ILMN_273393
3	   Narg1l	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  14	   53.3	   76.86	   2.87	   3.04	   -­‐0.18	  
ILMN_286164
4	   Rb1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  14	   18.7	   76.86	   3.27	   3.04	   0.10	  
ILMN_246276
2	   Wbp4	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  14	   4.7	   79.90	   0.04	   0.00	   -­‐0.14	  
ILMN_251378




k	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   14	   33.4	   79.90	   0.21	   0.00	   0.11	  
ILMN_124948
0	   1300010F03Rik	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  14	   61.0	   79.90	   0.30	   0.00	   -­‐0.21	  
ILMN_245921
1	   Dgkh	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  14	   62.4	   79.90	   0.90	   0.00	   -­‐0.20	  
ILMN_260643
6	   Diap3	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  14	   17.0	   79.90	   7.16	   0.00	   -­‐0.15	  
ILMN_272310
8	   Tgfb1i4	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  14	   5.1	   82.64	   5.74	   2.74	   0.01	  
ILMN_124850
8	   LOC382930	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  14	   5.3	   82.64	   10.78	   2.74	   0.00	  
ILMN_265068
3	   Tdrd3	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  14	   15.2	   85.99	   1.95	   6.09	   0.11	  
ILMN_123183




k	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   14	   40.6	   92.60	   1.08	   12.70	   -­‐0.17	  
ILMN_121433
7	   LOC386196	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  14	   8.5	   92.60	   10.62	   12.70	   -­‐0.06	  
ILMN_263929
1	   Cln5	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  14	   10.1	   92.60	   10.88	   12.70	   -­‐0.13	  




k	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   2	   62.1	   82.78	   0.95	   9.02	   0.12	  
ILMN_308893
4	   2700094K13Rik	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2	   4.7	   82.78	   1.73	   9.02	   0.07	  
ILMN_125447
3	   LOC241525	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2	   67.6	   82.78	   1.80	   9.02	   0.08	  
ILMN_296655
8	   Ypel4	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2	   59.6	   82.78	   1.80	   9.02	   0.11	  
ILMN_277542
1	   Serping1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2	   8.2	   82.78	   1.83	   9.02	   0.03	  
ILMN_289529
3	   BC003993	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2	   96.6	   82.78	   5.04	   9.02	   -­‐0.10	  
ILMN_275671
6	   Nup160	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2	   52.5	   82.78	   7.80	   9.02	   0.06	  
S.	  A.	  Kelly	  et	  al.	  12	  SI	  
ILMN_284858
3	   Mtch2	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2	   17.3	   82.78	   7.93	   9.02	   0.06	  
ILMN_279176
9	   Ddb2	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2	   7.9	   82.78	   8.28	   9.02	   -­‐0.02	  
ILMN_124148








k	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   2	   30.8	   89.55	   2.21	   2.25	   0.07	  
ILMN_122723
5	   Timm13a	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2	   13.0	   89.55	   4.88	   2.25	   0.05	  
ILMN_122066




k	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   2	   76.7	   89.60	   1.20	   2.25	   -­‐0.12	  
ILMN_268913
6	   Mybpc3	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2	   13.0	   89.60	   1.40	   2.25	   -­‐0.12	  
ILMN_258901
5	   Pacsin3	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2	   14.6	   91.83	   0.73	   0.03	   -­‐0.09	  
ILMN_274719
6	   Kai1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2	   9.0	   91.83	   1.43	   0.03	   -­‐0.12	  
ILMN_296075
0	   Traf6	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2	   6.8	   99.04	   2.50	   7.24	   0.04	  
ILMN_251176
8	   Ttc17	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2	   6.3	   99.04	   4.90	   7.24	   0.01	  
ILMN_262930
7	   4732486I23Rik	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2	   17.4	   99.04	   5.55	   7.24	   0.15	  
ILMN_122937
9	   Syt13	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2	   10.3	   99.04	   6.24	   7.24	   -­‐0.06	  
ILMN_122369
7	   Cd44	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2	   4.4	   102.76	   0.10	   10.96	   -­‐0.01	  
ILMN_273741
6	   Fjx1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2	   43.1	   102.76	   0.47	   10.96	   -­‐0.06	  
ILMN_282611
0	   Cat	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2	   42.9	   102.76	   0.54	   10.96	   -­‐0.13	  
ILMN_313152
2	   Fbxo3	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2	   10.6	   102.76	   1.14	   10.96	   0.08	  
ILMN_266076
6	   Cd59b	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2	   19.2	   102.76	   1.16	   10.96	   0.07	  
ILMN_123442
4	   G2-­‐pending	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2	   18.4	   102.76	   1.23	   10.96	   0.15	  
ILMN_314541




k	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   2	   35.3	   102.76	   1.77	   10.96	   0.04	  
ILMN_266902
3	   Nola3	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2	   5.1	   109.20	   2.90	   17.40	   0.01	  
ILMN_122787
4	   BC052040	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2	   4.6	   109.20	   6.41	   17.40	   -­‐0.05	  
ILMN_259295
3	   Sgne1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2	   26.6	   113.18	   0.43	   21.38	   -­‐0.04	  
ILMN_269077
2	   2610510L01Rik	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11 21.1	   3.78	   0.86	   6.12	   -­‐0.16	  
ILMN_290641
4	   1110014L17Rik	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11 16.8	   3.78	   2.39	   6.12	   -­‐0.07	  
ILMN_272750
3	   Igfbp3	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   4.6	   7.05	   0.06	   2.85	   -­‐0.02	  
S.	  A.	  Kelly	  et	  al.	   13	  SI	  
ILMN_271983
4	   Ccm2	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   17.7	   7.05	   0.56	   2.85	   -­‐0.10	  
ILMN_289108
5	   AB182283	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11 15.4	   7.05	   0.56	   2.85	   -­‐0.08	  
ILMN_268834




k	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   11	   37.6	   7.05	   1.02	   2.85	   -­‐0.11	  
ILMN_123600
9	   Camk2b	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   10.3	   7.05	   1.18	   2.85	   0.07	  
ILMN_281789




k	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   11	   29.8	   7.05	   1.37	   2.85	   -­‐0.10	  
ILMN_126033




k	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   11	   16.8	   7.05	   1.80	   2.85	   -­‐0.06	  
ILMN_123772
9	   Nefh	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   47.3	   7.05	   2.22	   2.85	   -­‐0.10	  
ILMN_261986
1	   Nipsnap1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   43.0	   7.05	   2.26	   2.85	   -­‐0.10	  
ILMN_283722




k	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   11	   5.2	   9.90	   7.20	   0.04	   -­‐0.02	  
ILMN_295929
1	   Upp1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   6.4	   9.94	   0.90	   0.04	   0.07	  
ILMN_122917
5	   Hus1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   4.5	   9.94	   1.05	   0.04	   0.04	  
ILMN_249146
9	   Tens1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   9.1	   9.94	   1.49	   0.04	   -­‐0.14	  
ILMN_258881




k	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   11	   5.1	   46.24	   1.96	   6.96	   0.05	  
ILMN_126025
2	   Trim41	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   10.9	   46.24	   2.38	   6.96	   0.02	  
ILMN_314467




k	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   11	   6.5	   46.24	   3.74	   6.96	   -­‐0.17	  
ILMN_263283
9	   1300007L22Rik	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11 17.4	   53.20	   0.00	   0.04	   -­‐0.07	  
ILMN_262114
8	   Kif3a	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   99.7	   53.20	   0.20	   0.04	   -­‐0.23	  
ILMN_123666
6	   Acsl6	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   66.2	   53.20	   0.90	   0.04	   -­‐0.18	  
ILMN_123072
6	   5430406J06Rik	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   34.6	   53.20	   1.40	   0.04	   -­‐0.12	  
ILMN_125117
0	   Laf4l	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   40.6	   53.24	   0.00	   0.04	   0.13	  
ILMN_125226
3	   Uqcrb	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   35.8	   53.24	   0.01	   0.04	   -­‐0.10	  
ILMN_123690
6	   D11Ertd497e	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   10.9	   53.24	   1.45	   0.04	   -­‐0.11	  
ILMN_271554
6	   Gpx3	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   6.1	   53.24	   1.49	   0.04	   0.13	  
S.	  A.	  Kelly	  et	  al.	  14	  SI	  
ILMN_241786
3	   Tnip1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   32.6	   53.24	   1.49	   0.04	   0.12	  
ILMN_124321
2	   Sparc	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   63.1	   53.24	   1.97	   0.04	   -­‐0.19	  
ILMN_122625
9	   Adamts2	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   15.5	   53.24	   2.62	   0.04	   0.07	  
ILMN_273478
9	   BC003251	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   7.5	   53.24	   4.92	   0.04	   0.03	  
ILMN_263570
8	   3100002J23Rik	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   23.5	   53.24	   5.37	   0.04	   0.14	  
ILMN_259760
6	   Gja12	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   16.5	   53.24	   5.75	   0.04	   0.11	  
ILMN_264801
2	   Gria1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   6.8	   56.50	   0.64	   3.30	   0.08	  
ILMN_309546
2	   Mfap3	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   12.1	   56.50	   0.84	   3.30	   -­‐0.09	  
ILMN_287878




k	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   11	   32.6	   56.50	   1.10	   3.30	   -­‐0.21	  
ILMN_312878
4	   Sap30l	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   19.2	   56.50	   1.12	   3.30	   0.15	  
ILMN_245972
0	   2510010K19Rik	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   5.9	   56.50	   1.32	   3.30	   -­‐0.09	  
ILMN_259355
4	   Igtp	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   7.7	   56.50	   1.52	   3.30	   -­‐0.12	  
ILMN_125956
4	   AI481100	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   4.6	   56.50	   1.53	   3.30	   -­‐0.11	  
ILMN_267466
8	   2810021J22Rik	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   4.4	   56.50	   2.19	   3.30	   0.14	  
ILMN_296757
6	   Guk1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   7.1	   56.50	   2.49	   3.30	   0.10	  
ILMN_258353
0	   7530424I01Rik	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   6.1	   56.50	   3.21	   3.30	   -­‐0.13	  
ILMN_125525
9	   AW050020	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   4.6	   56.50	   3.86	   3.30	   -­‐0.03	  
ILMN_271396




k	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   11	   4.7	   56.50	   5.03	   3.30	   -­‐0.15	  
ILMN_297943
0	   Thg1l	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   7.4	   56.50	   10.74	   3.30	   0.04	  
%	  Change	  in	  Body	  Mass	  
ILMN_124732




k	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   11	   24.0	   102.35	   102.35	   2.65	   -­‐0.02	  
ILMN_266259
5	   Mpp3	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   6.6	   102.35	   102.35	   2.65	   0.00	  
ILMN_121388
6	   Meox1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11 5.6	   102.35	   102.35	   2.65	   0.03	  
ILMN_276528
7	   Ccdc56	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   10.5	   102.35	   102.35	   2.65	   0.04	  
ILMN_251874
4	   Prkwnk4	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11 6.7	   102.35	   102.35	   2.65	   -­‐0.01	  
ILMN_125653
8	   LOC211895	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   9.9	   102.35	   102.35	   2.65	   0.08	  
S.	  A.	  Kelly	  et	  al.	   15	  SI	  
ILMN_288024
6	   Smarce1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11 4.6	   102.35	   102.35	   2.65	   0.02	  
ILMN_121789




k	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   11	   9.9	   102.35	   102.35	   2.65	   -­‐0.03	  
ILMN_123363
7	   LOC383899	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   4.4	   102.35	   102.35	   2.65	   0.05	  
ILMN_246489
8	   X83328	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11 4.7	   105.37	   105.37	   0.37	   -­‐0.02	  
ILMN_282262
2	   Mrpl10	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   5.6	   105.37	   105.37	   0.37	   -­‐0.04	  
ILMN_275425
3	   Gna13	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   8.6	   108.68	   108.68	   3.68	   -­‐0.04	  
ILMN_284043
0	   BC029169	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   5.5	   108.68	   108.68	   3.68	   -­‐0.04	  
ILMN_272569
8	   Cacng5	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   28.3	   108.68	   108.68	   3.68	   -­‐0.17	  
ILMN_123260
1	   Cyb561	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11 15.1	   108.68	   108.68	   3.68	   0.02	  
ILMN_268954
0	   Acbd4	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	   6.2	   108.68	   108.68	   3.68	   -­‐0.16	  
%	  Change	  in	  %	  Fat	  Mass	  
ILMN_242470
3	   4933426L22Rik	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   9.6	   170.02	   170.02	   7.98	   0.05	  
ILMN_291441
6	   Ncstn	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   12.8	   170.02	   170.02	   7.98	   -­‐0.21	  
ILMN_268577
0	   Ltap	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   27.6	   170.02	   170.02	   7.98	   -­‐0.23	  
ILMN_249593
9	   Usp21	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1 18.7	   170.02	   170.02	   7.98	   -­‐0.10	  
ILMN_254514
9	   6330408P19Rik	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   8.2	   170.02	   170.02	   7.98	   -­‐0.13	  
ILMN_244640
5	   LOC98434	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1 9.5	   170.02	   170.02	   7.98	   -­‐0.04	  
ILMN_255966
9	   Pbx1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   74.2	   170.02	   170.02	   7.98	   0.16	  
ILMN_274888
0	   4833414E09Rik	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   18.7	   170.02	   170.02	   7.98	   0.13	  
ILMN_257043
6	   A630043I21Rik	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   9.6	   170.02	   170.02	   7.98	   0.09	  
ILMN_260866
6	   Iqwd1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   8.6	   171.81	   171.81	   6.19	   0.17	  
ILMN_123963
8	   Pappa2	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1 15.7	   171.81	   171.81	   6.19	   0.19	  
ILMN_125412
3	   Usp23	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1 11.1	   171.81	   171.81	   6.19	   -­‐0.08	  
ILMN_125462
2	   Pcp4l1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   5.0	   171.81	   171.81	   6.19	   -­‐0.11	  
ILMN_259414
9	   Sdhc	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   18.1	   171.81	   171.81	   6.19	   0.04	  
ILMN_268740
3	   Fcgr3	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   42.4	   171.81	   171.81	   6.19	   0.16	  
ILMN_250254
2	   Uap1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   78.2	   171.81	   171.81	   6.19	   -­‐0.20	  
ILMN_297982
4	   Rgs5	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   6.4	   171.81	   171.81	   6.19	   0.09	  
S.	  A.	  Kelly	  et	  al.	  16	  SI	  
ILMN_288053
6	   Uck2	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   11.7	   175.07	   175.07	   2.93	   -­‐0.31*	  
ILMN_282681
6	   Ppox	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   24.0	   175.07	   175.07	   2.93	   -­‐0.14	  
ILMN_269726
6	   Refbp2	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   7.7	   175.07	   175.07	   2.93	   -­‐0.05	  
ILMN_121413
9	   Fmn2	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   56.8	   175.07	   175.07	   2.93	   -­‐0.18	  
ILMN_268190
6	   Copa	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   21.7	   175.07	   175.07	   2.93	   -­‐0.15	  
ILMN_297083
4	   Pex19	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   45.2	   175.07	   175.07	   2.93	   -­‐0.14	  
ILMN_262493
8	   Pea15	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   8.2	   175.07	   175.07	   2.93	   0.01	  
ILMN_124241
5	   Kcnj9	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   33.8	   175.07	   175.07	   2.93	   0.09	  
ILMN_316086
3	   Dusp23	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   19.0	   175.07	   175.07	   2.93	   -­‐0.13	  
ILMN_125466
3	   Igsf4b	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   16.6	   175.07	   175.07	   2.93	   0.05	  
ILMN_265674
8	   Dfy	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   14.6	   175.07	   175.07	   2.93	   -­‐0.12	  
ILMN_123256
1	   Rxrg	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   6.4	   178.74	   178.74	   0.74	   -­‐0.13	  
ILMN_314839
8	   Eprs	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   11.4	   178.74	   178.74	   0.74	   0.11	  
ILMN_123015




k	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   1	   6.7	   178.74	   178.74	   0.74	   -­‐0.13	  
ILMN_270947
0	   Degs	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   6.8	   178.74	   178.74	   0.74	   0.04	  
ILMN_299854
8	   Pycr2	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   15.1	   178.74	   178.74	   0.74	   -­‐0.13	  
ILMN_123721




6	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   1	   32.8	   178.74	   178.74	   0.74	   0.11	  
ILMN_125185
6	   Gpr125	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5 64.8	   49.99	   49.99	   40.01	   0.02	  
ILMN_263570
0	   Lgi2	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5	   27.1	   52.90	   52.90	   37.10	   -­‐0.06	  
ILMN_122526








k	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   5	   12.0	   65.04	   65.04	   24.96	   0.06	  
ILMN_265664




k	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   5	   13.1	   66.45	   66.45	   23.55	   -­‐0.08	  
ILMN_125525
6	   Sgcb	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5	   20.5	   67.96	   67.96	   22.04	   -­‐0.05	  
ILMN_124913
9	   B230209J16Rik	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5	   7.6	   67.96	   67.96	   22.04	   0.05	  
ILMN_250981
7	   Atp8a1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5	   48.0	   67.96	   67.96	   22.04	   0.07	  
S.	  A.	  Kelly	  et	  al.	   17	  SI	  
ILMN_123519








k	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   5	   58.5	   77.23	   77.23	   12.77	   -­‐0.14	  
ILMN_122539
0	   Asrij	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5	   41.6	   77.23	   77.23	   12.77	   0.03	  
ILMN_248217
8	   1810027I20Rik	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5	   26.0	   77.23	   77.23	   12.77	   0.11	  
ILMN_124881
2	   Srd5a2l	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5	   29.0	   77.23	   77.23	   12.77	   0.03	  
ILMN_268322




k	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   5	   5.3	   77.23	   77.23	   12.77	   -­‐0.04	  
ILMN_254801
0	   1110018K11Rik	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5	   25.1	   77.23	   77.23	   12.77	   -­‐0.08	  
ILMN_274782








k	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   5	   7.8	   78.14	   78.14	   11.86	   -­‐0.09	  
ILMN_267546
4	   Ankrd17	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5 30.9	   90.09	   90.09	   0.09	   0.08	  
ILMN_263303
9	   BC038311	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5	   49.6	   90.09	   90.09	   0.09	   -­‐0.15	  
ILMN_300201
1	   Cox18	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5	   12.5	   93.05	   93.05	   3.05	   -­‐0.13	  
ILMN_270023
3	   Ccng2	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5	   73.8	   93.05	   93.05	   3.05	   0.07	  
ILMN_266674
7	   E430034L04Rik	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5 11.1	   93.05	   93.05	   3.05	   -­‐0.15	  
ILMN_244912
0	   D5Ertd606e	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5 17.6	   93.05	   93.05	   3.05	   -­‐0.13	  
ILMN_125027
8	   Sdad1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5	   6.0	   93.05	   93.05	   3.05	   0.07	  
ILMN_266321




k	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   5	   4.9	   96.86	   96.86	   6.86	   0.03	  
ILMN_313578
1	   Anxa3	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5	   19.5	   96.86	   96.86	   6.86	   -­‐0.01	  
ILMN_298046




k	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   5	   15.1	   99.48	   99.48	   9.48	   0.06	  
ILMN_123837
4	   Cdc7	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5	   4.5	   99.48	   99.48	   9.48	   0.02	  
ILMN_286632
7	   Pkd2	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5	   19.3	   99.48	   99.48	   9.48	   -­‐0.05	  
ILMN_277811




k	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   5	   6.2	   99.48	   99.48	   9.48	   0.06	  
ILMN_300926
0	   Coq2	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5	   10.4	   99.48	   99.48	   9.48	   0.04	  




k	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   5	   19.2	   99.48	   99.48	   9.48	   0.07	  
%	  Change	  in	  %	  Lean	  Mass	  
ILMN_123519








k	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   5	   58.5	   77.23	   77.23	   15.77	   0.07	  
ILMN_122539
0	   Asrij	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5	   41.6	   77.23	   77.23	   15.77	   0.00	  
ILMN_248217
8	   1810027I20Rik	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5	   26.0	   77.23	   77.23	   15.77	   -­‐0.06	  
ILMN_268322




k	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   5	   5.3	   77.23	   77.23	   15.77	   -­‐0.03	  
ILMN_254801








k	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   5	   7.8	   78.14	   78.14	   14.86	   0.09	  
ILMN_267546
4	   Ankrd17	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5 30.9	   90.09	   90.09	   2.91	   -­‐0.08	  
ILMN_263303
9	   BC038311	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5	   49.6	   90.09	   90.09	   2.91	   0.13	  
ILMN_300201
1	   Cox18	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5	   12.5	   93.05	   93.05	   0.05	   0.10	  
ILMN_270023
3	   Ccng2	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5	   73.8	   93.05	   93.05	   0.05	   -­‐0.06	  
ILMN_266674
7	   E430034L04Rik	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5 11.1	   93.05	   93.05	   0.05	   0.10	  
ILMN_244912
0	   D5Ertd606e	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5 17.6	   93.05	   93.05	   0.05	   0.10	  
ILMN_125027




k	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   5	   4.9	   96.86	   96.86	   3.86	   -­‐0.08	  
ILMN_313578
1	   Anxa3	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5	   19.5	   96.86	   96.86	   3.86	   -­‐0.02	  
ILMN_298046




k	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   5	   15.1	   99.48	   99.48	   6.48	   -­‐0.03	  
ILMN_123837
4	   Cdc7	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5	   4.5	   99.48	   99.48	   6.48	   -­‐0.05	  
ILMN_286632
7	   Pkd2	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5	   19.3	   99.48	   99.48	   6.48	   0.05	  
ILMN_277811




k	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   5	   6.2	   99.48	   99.48	   6.48	   -­‐0.02	  
ILMN_300926




k	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   5	   19.2	   99.48	   99.48	   6.48	   -­‐0.05	  
	  
